Paris, France – 1st of February 2023

The SYNBEE project – SYNthetic Biology Entrepreneurial Ecosystem, funded under the European Commission’s Horizon Europe Research and Innovation Programme, with an aim to expand entrepreneurial ecosystems built around synthetic biology.

Coordinated by eureKARE from Paris (France), the SYNBEE network brings together 14 leading business, research and academic institutions from 8 countries (France, Finland, Latvia, Ireland, Germany, United Kingdom, United States) with the ambition to harness the entrepreneurial potential of  synthetic biology as an industry.

Synthetic biology is a disruptive technology that enables completely new processes and products for industry, medical applications and food production, while making them cheaper and more sustainable. Leading European research organizations have a proven scientific track record of excellence in the field, but remain largely under-exploited commercially.

Over the next 2 years, the main goal of the SYNBEE initiative will be to enhance entrepreneurial education of young synthetic biology professionals across European innovation ecosystems, thus improving their employability while empowering entrepreneurs to build synthetic biology companies in Europe and potentially create future unicorns.

SYNBEE’s unique methodology will be implemented by key synthetic biology players, including academic centers of excellence and their accelerators, incubators, and technology transfer offices, as well as industry partners and investors from 25 European countries who share this common goal.

Project details:

Project No: 101100509
Start date: 15/01/2023
Project duration: 24 months

Beneficiaries:
EUREKARE (FR)
HAMEEN AMMATTIKORKEAKOULU OY (FI)
TECHNISCHE UNIVERSITEIT DELFT (NL)
INRAE TRANSFERT SAS (FR)
BIOCATALYST NODIBINAJUMS (LV)
F6S NETWORK IRELAND LIMITED (IR)
RIGAS TEHNISKA UNIVERSITATE (LV)

Associated Partners:

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV (DE)
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (UK)
Potter Clarkson LLP (UK)
Start Codon Limited (UK)
iGEM Foundation, Inc. (US)
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR)
German Association for Synthetic Biology e. V. (DE)

Horizon Europe Research and Innovation Programme:

Horizon Europe is the EU’s key funding programme for research and innovation with a budget of €95.5 billion. It tackles climate change, helps to achieve the UN’s Sustainable Development Goals and boosts the EU’s competitiveness and growth. The programme facilitates collaboration and strengthens the impact of research and innovation in developing, supporting and implementing EU policies while tackling global challenges. It supports creating and better dispersing of excellent knowledge and technologies. It creates jobs, fully engages the EU’s talent pool, boosts economic growth, promotes industrial competitiveness and optimizes investment impact within a strengthened European Research Area.

Project coordination contact point:

Alexandra Chukas, European Grant Coordinator Da Vinci Labs (alexandra.chukas@davincilabs.eu )

PR contact point:

Andréia Santos, EU Project Manager at F6S

( andreia@f6s.com )

Sara Canedo, Communications Manager at F6S

( sarafc@f6s.com )

 

Disclaimer: Funded by the European Union under the Grant Agreement No 101100509. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authorities can be held responsible for them.